3D). After 4 wk, three to five times more CD34+ cells were present in those cultures using IL-32 than in control samples (p<0.018, Table 2). These differences were

in part accompanied by a higher number of 2-wk cobblestones formed by cells cultured in IL-32 plus SCF (p<0.015) than those formed by cells cultured in SCF alone. The highest numbers of 5-wk cobblestones, an indicator for more primitive HPCs, were achieved in cultures supplemented with 100 ng/mL IL-32 (compared with intra-assay control p=0.014). After 2 wk in culture, the frequency of CD34+ cells ranged from 5 to 39%. The IL-32 expanded cells continued to be positive for CD34 until the end of the culture period; they also increasingly expressed CD45, indicating AZD1208 datasheet leukocyte differentiation (Fig. 4A and B). The cells’ colony-forming capacity, especially the total number of burst-forming unit erythrocyte and the plating efficiency were significantly better than in control

cultures consisting of medium only (Fig. 4C). The total numbers of colonies of cells cultured with IL-32 were equivalent to those cultured in SCF alone, while they led to a significantly higher plating efficiency (11±1.3% versus 4.9±0.43%, p<0.001). The other potential growth factors we tested led to significantly fewer numbers of colonies than SCF (Supporting Information Fig.). Injections of 5-fluorouracil (FU) produce profound myelosuppression in Balb/c mice within 7 days, and regeneration usually begins around day 10 24. In our study, myelosuppression was attenuated when this website human recombinant IL-32 was applied after 5-FU treatment. Both white blood cell (WBC) and platelet counts were significantly higher in mice treated with IL-32 on day 7 (Fig. 5A and B). On day 4, WBC counts were 30% higher, if 5 μg IL-32 had been administered (97.5±15×108/L versus normal saline 68.6±5.5×108/L, p<0.03). On day 7, the difference was even more prominent (53±6.6×108/L versus normal saline 33.6±3.1×108/L, p=0.011), which paralleled significantly higher monocyte counts (191.2±41.8×106 versus normal saline 34.5±10.1×106, p=0.002).

On this day, platelet counts of mice treated with 5 μg IL-32 were also significantly higher than in the control group (169.4±11×109/L versus normal saline 130.2±10.3×109/L, p=0.013), and they were surpassed by platelet counts in Phosphoglycerate kinase mice, which had received the high dosage of 50 μg IL-32 (216.9±22.4×109/L, p=0.038). Though the number of thrombocytes seemed to be higher in IL-32 treated mice on days 10 and 14, differences discontinued to be significant (p>0.1). On day 14, twice the number of granulocytes was present in mice treated with 50 μg IL-32 compared with the normal saline group (1315.6±344×106 versus 670.3±290.8×106, p=0.04). No differences between the three different treatment groups were found in the hemoglobin contents, hematocrits, lymphocyte and red blood cell counts.